References

  1. Aach RD, Szmuness W, Mosley JW, Hollinger FB, Kahn RA, Stevens CE, et al. Serum alanine aminotransferase of donors in relation to the risk of non-A,non-B hepatitis in recipients: the transfusion-transmitted viruses study. N Engl J Med. 1981; 304(17):989-94. PubMed | Google Scholar

  2. Niederhauser C, Schneider P, Fopp M, Ruefer A, Levy G. Incidence of viral markers and evaluation of the estimated risk in the Swiss blood donor population from 1996 to 2003. Euro Surveill. 2005; 10(2):14-6. PubMed | Google Scholar

  3. El-Sherif AM, Abou-Shady MA, Al-Hiatmy MA, Al-Bahrawy AM, Motawea EA. Screening for hepatitis B virus infection in Egyptian blood donors negative for hepatitis B surface antigen. Hepatol Int. 2007; 1(4):469-70. PubMed | Google Scholar

  4. World Health Organisation. Blood Transfusion Service: Global database on blood safety from 1998-1991. Geneva, WHO/BTS. 2001; Summary report. Google Scholar

  5. Busch MP, Glynn SA, Stramer SL, Strong DM, Caglioti S, Wright DJ, et al. A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors. Transfusion. 2005;45(2):254-64. PubMed | Google Scholar

  6. McClelland DBL. Handbook of transfusion medicine : blood transfusion services of the United Kingdom. 2nd ed ed London: HMSO.1996. Google Scholar

  7. Gallarda JL, Dragon E. Blood screening by nucleic acid amplification technology: current issues, future challenges. Mol Diagn. 2000; 5(1):11-22. PubMed | Google Scholar

  8. Basavaraju SV, Mwangi J, Nyamongo J, Zeh C, Kimani D, Shiraishi RW, et al. Reduced risk of transfusion-transmitted HIV in Kenya through centrally co-ordinated blood centres, stringent donor selection and effective p24 antigen-HIV antibody screening. Vox Sang. 2010; 99(3):212-9. PubMed | Google Scholar

  9. Busch MP, Dodd RY. NAT and blood safety: what is the paradigm?. Transfusion. 2000; 40(10):1157-60. PubMed | Google Scholar

  10. Allain JP, Lee H. Rapid tests for detection of viral markers in blood transfusion. Expert Rev Mol Diagn. 2005; 5(1):31-41. PubMed | Google Scholar

  11. Rahman M, Khan SA, Lodhi Y. Unconfirmed reactive screening tests and their impact on donor management. Pak J Med Sci. 2008; 24(4):517-19. PubMed | Google Scholar

  12. Torane VP, Shastri JS. Comparison of ELISA and rapid screening tests for the diagnosis of HIV, Hepatitis B and Hepatitis C among healthy blood donors in a tertiary care hospital in Mumbai. Indian J Med Microbiol. 2008; 26(3):284-5. PubMed | Google Scholar

  13. Ampofo W, Nii-Trebi N, Ansah J, Abe K, Naito H, Aidoo S, et al. Prevalence of blood-borne infectious diseases in blood donors in Ghana. J Clin Microbiol. 2002; 40(9):3523-5. PubMed | Google Scholar

  14. Allain JP, Candotti D, Soldan K, Sarkodie F, Phelps B, Giachetti C, et al. The risk of hepatitis B virus infection by transfusion in Kumasi, Ghana. Blood. 2003; 101(6):2419-25. PubMed | Google Scholar

  15. World Health Oorganisation. Screening donated blood for transfusion-transmissible infections:Recommendations. WHO publication. 2009;6. Google Scholar

  16. World Health Oorganisation. Screening donated blood for transfusion-transmissible infections:Recommendations. WHO publication. 2009;6. Google Scholar

  17. Akobeng KA. Understanding diagnostic tests: sensitivity, specificity and predictive values. Acta Paediatr. 2006; 96:338-41. PubMed | Google Scholar

  18. Youden WJ. Index for rating diagnostic tests. Cancer. 1950; 3(1):32-5. PubMed | Google Scholar

  19. Smits N. A note on Youden's J and its cost ratio. BMC Med Res Methodol. 2010; 10:89. PubMed | Google Scholar

  20. Šimundic AM. Measures of diagnostic accuracy: basic definitions. www.ifcc.org/ifccfiles/docs/190404200805.pdf: Department of Molecular Diagnostics,University Department of Chemistry, Sestre milosrdnice University Hospital, Zagred, Croatia. 2009; 1-9. Google Scholar

  21. Agresti A, Coull BA. Approximate is better than "exact" for interval estimation of binomial proportions. The American Statistician. 1998; 52:119-26. PubMed | Google Scholar

  22. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986; 1(8476):307-10. PubMed | Google Scholar

  23. Kaadan AN, Dragon, M. Blood Transfusion in History. www.bloodtransfusioninhistory.pdf. 2009. Google Scholar

  24. Tagny CT, Mbanya D, Tapko JB, Lefrere JJ. Blood safety in Sub-Saharan Africa: a multi-factorial problem. Transfusion. 2008; 48(6):1256-61. PubMed | Google Scholar

  25. Owiredu WKBA, Osei-Yeboah J, Amidu N, Laing EF. Residual Risk of Transmission of Hepatitis B Virus through Blood Transfusion in Ghana: Evaluation of the performance of Rapid Immunochromatographic Assay with Enzyme Linked Immunosorbrnt Assay. Journal of Medical and Biomedical Sciences. 2012; 1(2):17-28. PubMed | Google Scholar

  26. World Health Organisation. Screening donated blood for transfusion-transmissible infections:Recommendations. WHO publication. 2009; 6. Google Scholar

  27. Kwenti TE, Njouom R, Njunda LA, Kamga HLF. Comparison of an Immunochromatographic Rapid Strip Test, ELISA and PCR in the Diagnosis of Hepatitis C in HIV Patients in Hospital Settings in Cameroon. Clinical Medicine and Diagnostics. 2011; 1(1):21-27. PubMed | Google Scholar

  28. Schroter M, Feucht HH, Schafer P, Zollner B, Polywka S, Laufs R. Definition of false-positive reactions in screening for hepatitis C virus antibodies. J Clin Microbiol. 1999; 37(1):233-34. PubMed | Google Scholar

  29. Vardas E, Sitas F, Seidel K, Casteling A, Sim J. Prevalence of hepatitis C virus antibodies and genotypes in asymptomatic, first-time blood donors in Namibia. Bull World Health Organ. 1999; 77(12):965-72. PubMed | Google Scholar

&